In a significant legal ruling, Bayer AG has been ordered by a Washington state jury to pay $100 million to four individuals who claim they suffered health issues due to exposure to polychlorinated ...
— Bayer 04 Leverkusen (@bayer04_en) January 29, 2025 Buendia joined Villa from Norwich City in 2021 in a deal worth more than £30million (now $37.3m) and has made 97 appearances for the club ...
Bayern Munich are set to play in their UEFA Champions League knockout stage play-offs. Vincent Kompany's side finished 12th in the new league format. They won five of their eight games, finishing ...
Bayern Munich enter Wednesday's Champions League Matchday 8 knowing that they will at least be in the playoffs, but a victory and some help could lock up a spot in the top-eight for the Bavarians.
Defending Bundesliga champions Bayer Leverkusen have only lost once in the league so far this season, so how come they're six points behind leaders Bayern Munich? First-half goals from Patrik ...
Even though other top European clubs could be vying for the player’s signature, the Red Devils reportedly have the ‘upper hand’.
Leverkusen's Patrik Schick, left, and Mainz's Stefan Bell jump for the ball during the German Bundesliga soccer match between Bayer Leverkusen and FSV Mainz at the BayArena in Leverkusen ...
Bayer’s hot flash drug candidate has hit the mark in a phase 3 breast cancer trial, potentially positioning the German drugmaker to get the jump on Astellas’ rival drug Veozah. Astellas won ...
Bayer will provide a minimum of $300 million in R&D investments to the JV over the next five years, and will acquire a minority stake in CRISPR Therapeutics for $35 million in cash.
BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane ...
Two goals from Patrik Schick helped Bayer Leverkusen battle past Borussia Dortmund to a 3-2 victory on Friday, claiming a sixth-straight league win. (More Football News) Dortmund suffered their ...
Although Bayer’s top-selling drug Xarelto lost market exclusivity in most geographies in 2024, the company still predicts it will see strong growth from the pharma business unit beginning in 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results